CFO
TNDM icon

CVA Family Office’s Tandem Diabetes Care TNDM Stock Holding History

CVA Family Office’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$467 – 1342
2024
Q3 		$467 Hold
11
– – ﹤0.01% 1234
2024
Q2 		$443 Buy
+11
New +$459 ﹤0.01% 1250
2022
Q2 		– Sell
-15
Closed -$2K – 989
2022
Q1 		$2K Hold
15
– – ﹤0.01% 884
2021
Q4 		$2K Buy
+15
New +$2.02K ﹤0.01% 849
2021
Q3 		– Sell
-15
Closed -$1K – 832
2021
Q2 		$1K Buy
+15
New +$1.34K ﹤0.01% 931

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVA Family Office's TNDM Position: Q4 2024 in Review

CVA Family Office sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 11 shares — an estimated $467 sold.

CVA Family Office first reported a position in TNDM in Q2 2021 and held it in 5 quarters. The position peaked at $2K in Q1 2022. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • CVA Family Office reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • CVA Family Office sold 11 Tandem Diabetes Care shares in Q4 2024, an estimated $467.
  • CVA Family Office first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 5 quarters.
  • CVA Family Office's Tandem Diabetes Care position peaked at $2K in Q1 2022.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.